Key Takeaway
Your GLP-1 provider check-in is your chance to improve your treatment. But showing up unprepared means you miss the opportunity to get the most from your provider's expertise.
Your GLP-1 provider check-in is your chance to improve your treatment. But showing up unprepared means you miss the opportunity to get the most from your provider's expertise. The patients who see the best results are the ones who come prepared with data, specific questions, and an honest assessment of how things are going. Here is how to make every GLP-1 provider check-in count.
Key Takeaways: - Understand what to bring to your check-in - Questions Worth Asking Your Provider - Learn how to give honest feedback - Making the Most of Virtual Check-Ins
What to Bring to Your Check-In
Preparation takes 10-15 minutes and can change the entire trajectory of your treatment.
Your dose log. Bring a complete record of every injection since your last visit. Include dates, doses, injection sites, and any notes about how you felt. If you use the , you can pull up your dose history in seconds. Your provider uses this data to evaluate your compliance and make informed titration decisions.
Weight and measurement trends. Don't just tell your provider what you weigh today. Show them the trend over the past 4-8 weeks. A 2-pound weight loss this week doesn't mean much on its own. But showing a consistent downward trend over two months tells a powerful story.
Side effect notes. Be specific about any side effects you experienced. When did they occur relative to your injection? How severe were they on a scale of 1-10? How long did they last? Did anything help manage them? Vague statements like "I had some nausea" are less useful than "I had nausea rating 6/10 on days 1-2 after injection, lasting about 4 hours each time, improved by sipping ginger tea."
Food and activity summary. Your provider needs context about your lifestyle habits to make good protocol decisions. Bring a general summary of your eating patterns, average daily protein intake, exercise frequency and type, and any major changes since your last visit.
Questions you want answered. Write them down. People forget questions in the moment. Prepare 2-3 specific questions before your visit so you leave with the information you need.
"The key to successful GLP-1 therapy is setting realistic expectations and supporting patients through the titration phase. The side effects are manageable for most people, but they need to know what to expect.") Dr. Caroline Apovian, MD, Harvard Medical School
Free Download: GLP-1 Progress Report Template Our printable check-in preparation sheet compiles all the data your provider needs in one organized format. Fill it out before your appointment. Get yours free (we'll email it to you instantly.
[Download CTA Button]
Questions Worth Asking Your Provider
Here are specific, productive questions that lead to better treatment decisions.
View data table
| Category | Impact on Treatment Outcomes (%) | Detail |
|---|---|---|
| Protein Intake | 90 | Preserves muscle mass |
| Exercise | 85 | Enhances weight loss |
| Sleep Quality | 78 | Supports metabolism |
| Hydration | 72 | Reduces side effects |
| Stress Mgmt | 65 | Cortisol reduction |
About your dose: "Based on my tracking data, do you think my current dose is optimal, or should we discuss a change?" This opens the titration conversation with data backing. Your provider can review your and appetite response to make a more precise recommendation.
About your nutrition: "Am I getting enough protein to preserve muscle mass? What should I be eating differently?" Many patients undereat protein during GLP-1 treatment. Ask your provider for specific targets based on your body composition and goals. Our is a helpful companion resource.
About your timeline: "Based on my current progress, what is a realistic expectation for the next 3 months?" This helps you calibrate expectations and stay motivated with a clear horizon.
About lab work: "Are there any blood tests we should order before our next check-in?" Regular monitoring of metabolic markers helps track improvements that the scale can't show.
About stalls: "I have been plateaued for X weeks. What adjustments would you recommend?" Come with your tracking data so your provider can see what has and hasn't changed during the stall.
About long-term planning: "What is the plan for when I reach my goal weight? Will I stay on medication, taper, or transition?" Understanding the long-term plan reduces anxiety about the future and helps you prepare mentally and practically.
How to Give Honest Feedback
The most productive check-ins involve honest communication, even when the truth is uncomfortable.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Admit when you haven't been compliant. Missed doses, poor eating weeks, or skipped workouts happen. Your provider isn't there to judge you. They need accurate information to help you. If you missed 2 out of 4 weekly doses last month, say so. Pretending you were compliant while your results don't match leads to incorrect protocol adjustments.
Describe your appetite honestly. If you're still hungry most of the time, your dose may need adjustment. If your appetite is so suppressed that you're eating under 800 calories daily, that's also important information. Both extremes affect your treatment plan.
Report all side effects. Some patients minimize side effects because they don't want their dose reduced. But unreported side effects can indicate your body needs a different approach. Your provider can often find solutions that manage side effects without sacrificing results.
Share your emotional experience. How you feel about your progress matters. If you're feeling frustrated, anxious, or discouraged, your provider should know. They can adjust expectations, offer encouragement, or connect you with additional support resources.
Be specific about what is working. Positive feedback helps your provider know what to keep doing. "I am sleeping better since we adjusted my injection timing" gives your provider useful data.
Track all of this in the between appointments so you don't have to rely on memory. Review your app data the night before your check-in to refresh your recollection. If you're also on a , bring that tracking data as well.
Making the Most of Virtual Check-Ins
Many FormBlends check-ins happen virtually. Here is how to maximize a telehealth appointment.
Test your tech beforehand. Make sure your camera, microphone, and internet connection work. Nothing wastes appointment time like troubleshooting technology issues during the first five minutes.
Have your data ready on screen. Open your or have your tracking spreadsheet ready to share or reference during the call. If your provider uses a portal, upload your data before the appointment if possible.
Find a private, quiet space. You'll be discussing personal health information. Make sure you can speak freely without interruptions or eavesdropping.
Take notes during the appointment. Write down your provider's recommendations, any dose changes, when to schedule your next appointment, and what to track between now and then. It's easy to forget specifics after the call ends.
Follow up in writing. If your provider gives you new instructions, send a confirmation message through the patient portal summarizing what you understood. This prevents miscommunication about dose changes or other protocol adjustments.
Frequently Asked Questions
How often should I have GLP-1 provider check-ins?
Most providers schedule check-ins every 4-6 weeks during active titration and every 2-3 months once you're on a stable dose. If you experience significant side effects or a prolonged plateau, you can request an earlier appointment.
What if I disagree with my provider's recommendation?
Express your concerns respectfully and ask for the reasoning behind the recommendation. A good provider will explain their thinking and consider your perspective. If you remain uncomfortable, it's okay to seek a second opinion or request time to think about the proposed change.
Should I weigh myself the morning of my check-in?
Yes, your current weight is useful data. But also bring your weight trend over the past weeks. Your provider cares more about the trajectory than today's number, since daily weight can fluctuate by several pounds.
What if I haven't been tracking consistently?
Start now. Even a few days of tracking before your appointment is better than nothing. Be honest with your provider about the gap in your data. They can still make recommendations based on what you remember and your current metrics.
Can I email my provider with questions between check-ins?
Most providers and platforms, including , offer messaging between appointments. Use this for specific questions, side effect concerns, or updates that can't wait until your next scheduled check-in. Keep messages concise and actionable.
Start your progress Today
Every transformation starts with a single step. Talk to a licensed FormBlends provider about whether this approach is right for you) consultations are free and confidential.
Medical References
- Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet. 2021;397(10278):971-984. [PubMed | ClinicalTrials.gov | DOI]
- Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3). JAMA. 2021;325(14):1403-1413. [PubMed | ClinicalTrials.gov | DOI]
- Garvey WT, Batterham RL, Bhatt DL, et al. Two-year effects of semaglutide in adults with overweight or obesity (STEP 5). Nat Med. 2022;28(10):2083-2091. [PubMed | ClinicalTrials.gov | DOI]
- Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2). Lancet. 2023;402(10402):613-626. [PubMed | ClinicalTrials.gov | DOI]
- Wadden TA, Chao AM, Engel S, et al. Tirzepatide with intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3). Nat Med. 2024. [PubMed | ClinicalTrials.gov | DOI]
- Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4). JAMA. 2024;331(1):38-48. [PubMed | ClinicalTrials.gov | DOI]
Sources &. References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183
- Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2[1] (Davies et al., Lancet, 2021)). Lancet. 2021;397(10278):971-984. Doi:10.1016/S0140-6736(21)00213-0
- Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3[2] (Wadden et al., JAMA, 2021)). JAMA. 2021;325(14):1403-1413. Doi:10.1001/jama.2021.1831
- Garvey WT, Batterham RL, Bhatt DL, et al. Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5[3] (Garvey et al., Nat Med, 2022)). Nat Med. 2022;28:2083-2091. Doi:10.1038/s41591-022-02026-4
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. Doi:10.1056/NEJMoa2307563
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. Doi:10.1056/NEJMoa2206038
- Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2[4] (Garvey et al., Lancet, 2023)). Lancet. 2023;402(10402):613-626. Doi:10.1016/S0140-6736(23)01200-X
- Wadden TA, Chao AM, Engel S, et al. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3[5] (Wadden et al., Nat Med, 2023)). Nat Med. 2023. Doi:10.1038/s41591-023-02597-w
- Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4[6] (Aronne et al., JAMA, 2024)). JAMA. 2024;331(1):38-48. Doi:10.1001/jama.2023.24945
- Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med. 2024;391:1193-1205. Doi:10.1056/NEJMoa2404881
- Stierman B, Afful J, Carroll MD, et al. National Health and Nutrition Examination Survey 2017-March 2020 Prepandemic Data Files. NCHS Data Brief. No. 492. CDC/NCHS. 2023.
- Sumithran P, Prendergast LA, Delbridge E, et al. Long-Term Persistence of Hormonal Adaptations to Weight Loss. N Engl J Med. 2011;365(17):1597-1604. Doi:10.1056/NEJMoa1105816
The information in this article is intended for educational use only and shouldn't be considered medical advice. Consult a qualified healthcare provider before making any changes to your medication or supplement regimen. FormBlends helps with connections with licensed providers for personalized medical guidance.
Last updated: 2026-03-24